Erratum: Measurement of fractional exhaled nitric oxide in stable bronchiectasis (Tuberculosis and Respiratory Diseases (2013) 74, 1, (7-14) DOI: 10.4046/trd.2013.74.1.7);Measurement of fractional exhaled nitric oxide in stable bronchiectasis

Tuberculosis and Respiratory Diseases

Volumn 74, Issue 1, 2013, Pages 7-14

  Cho, Young Jae ^a   Lim, Hyo Jeong ^a   Park, Jong Sun ^a   Lee, Jae Ho ^a   Lee, Choon Taek ^a   Yoon, Ho Il ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Bronchiectasis; Nitric oxide; Nontuberculous mycobacteria

Indexed keywords

FRACTIONAL EXHALED NITRIC OXIDE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTHMA; ATYPICAL MYCOBACTERIOSIS; BLOOD CELL COUNT; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHIL COUNT; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; MALE; MEDICAL RECORD REVIEW; RETROSPECTIVE STUDY; SPIROMETRY; SPUTUM EXAMINATION;

EID: 84874452552     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2013.74.4.195     Document Type: Erratum

References (17)

1. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-8. (Pubitemid 24191108)
2. Kim SH, Yoon HJ. Use of the exhaled nitric oxide for management of asthma and respiratory diseases. Korean J Med 2008;74:579-86.
3. Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 2010;138:682-92.
4. Kharitonov SA, Wells AU, O'Connor BJ, Cole PJ, Hansell DM, Logan-Sinclair RB, et al. Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med 1995;151:1889-93.
5. Wang CH, Liu CY, Lin HC, Yu CT, Chung KF, Kuo HP. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J 1998;11:809-15. (Pubitemid 28231271)
6. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184:602-15.
7. Kim C, Kim DG. Bronchiectasis. Tuberc Respir Dis 2012;73:249-57.
8. Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest 2006;130:1541-6. (Pubitemid 44786751)
9. Tsang KW, Leung R, Fung PC, Chan SL, Tipoe GL, Ooi GC, et al. Exhaled and sputum nitric oxide in bronchiectasis: correlation with clinical parameters. Chest 2002;121:88-94. (Pubitemid 34114232)
10. Ho LP, Innes JA, Greening AP. Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis. Eur Respir J 1998;12:1290-4. (Pubitemid 29011417)
11. Narang I, Ersu R, Wilson NM, Bush A. Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance. Thorax 2002;57:586-9. (Pubitemid 34761759)
12. Shoemark A, Devaraj A, Meister M, Ozerovitch L, Hansell DM, Wilson R. Elevated peripheral airway nitric oxide in bronchiectasis reflects disease severity. Respir Med 2011;105:885-91.
13. Van Beek SC, Nhung NV, Sy DN, Sterk PJ, Tiemersma EW, Cobelens FG. Measurement of exhaled nitric oxide as a potential screening tool for pulmonary tuberculosis. Int J Tuberc Lung Dis 2011;15:185-92.
14. Ryoo SW, Shin S, Shim MS, Park YS, Lew WJ, Park SN, et al. Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans. J Clin Lab Anal 2008;22:415-20.
15. Oikonomou A, Tsanakas J, Hatziagorou E, Kirvassilis F, Efremidis S, Prassopoulos P. High resolution computed tomography of the chest in cystic fibrosis (CF): is simplification of scoring systems feasible? Eur Radiol 2008; 18:538-47. (Pubitemid 351248184)
16. Idh J, Westman A, Elias D, Moges F, Getachew A, Gelaw A, et al. Nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection. BMC Infect Dis 2008;8:146.
17. Robroeks CM, Roozeboom MH, de Jong PA, Tiddens HA, Jobsis Q, Hendriks HJ, et al. Structural lung changes, lung function, and non-invasive inflammatory markers in cystic fibrosis. Pediatr Allergy Immunol 2010;21:493-500.